Interpretation of surrogate endpoints in the era of the 21st Century Cures Act

Pages: i6286 - i6286
Published: Dec 30, 2016
Abstract
Surrogate endpoints are commonly used in clinical trials to get quicker results, but Kevin Knopf and colleagues show how they can lead to both medical and financial harm The rationale behind medical practice distils to three principles: maintaining health (wellbeing), improving quality of life, and extending length of life. For patients with incurable cancer, quality and length of life are of prime importance and should therefore be the...
Paper Details
Title
Interpretation of surrogate endpoints in the era of the 21st Century Cures Act
Published Date
Dec 30, 2016
Journal
Pages
i6286 - i6286
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.